Fmoc Deprotection Bases That Reduce Aspartimide in Peptide Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for fluorenylmethoxycarbonyl (Fmoc) deprotection in solid-phase peptide synthesis face challenges such as high costs, unpleasant odor, regulatory issues, and the formation of aspartimide, which leads to α- or β-peptide hydrolysis, particularly when using piperidine or piperazine-based reagents.
Innovation Solution
The use of dibutylamine or dipropylamine as a base for Fmoc deprotection in solid-phase peptide synthesis, which reduces aspartimide formation and provides cost-effective, odor-free alternatives, allowing for higher reaction temperatures and improved peptide yields.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If piperidine is used as Fmoc deprotection reagent, then deprotection efficiency is improved, but cost increases and unpleasant odor is generated
Solution Approach 1:
The patent replaces expensive piperidine with cheaper alternative bases such as dibutylamine, dipropylamine, or diethylamine that provide comparable deprotection efficiency without the harmful odor and regulatory issues associated with piperidine. These alternative reagents are less regulated, cheaper, and odor-free while maintaining the necessary chemical functionality for Fmoc removal.
Solution Approach 2:
The patent modifies the chemical parameters of the deprotection reagent by changing from piperidine to other amine bases with different physical and chemical properties. This substitution maintains the base strength needed for efficient Fmoc deprotection while eliminating the harmful odor and regulatory problems, achieving parameter optimization without sacrificing performance.
2Productivity
If piperidine or piperazine is used for Fmoc deprotection, then deprotection works effectively, but aspartimide formation increases leading to peptide hydrolysis
Solution Approach 1:
The patent employs alternative amine bases such as dibutylamine, dipropylamine, or diethylamine that are chemically similar to piperidine but produce fewer aspartimide byproducts. These reagents maintain effective deprotection while improving peptide integrity by reducing the formation of harmful aspartimide intermediates that lead to hydrolysis.
Solution Approach 2:
The patent converts the potentially harmful effect of strong bases (which cause aspartimide formation) into a beneficial process by selecting alternative amine bases that provide sufficient basicity for deprotection while being less prone to forming aspartimide. This transforms a harmful side reaction into a more controlled and desirable process.
3Productivity
If piperidine is used as Fmoc removal reagent, then synthesis proceeds efficiently, but regulatory issues arise due to use in illegal drug manufacturing
Solution Approach 1:
The patent replaces piperidine with alternative amine bases such as dibutylamine, dipropylamine, or diethylamine that are not associated with illegal drug manufacturing. These reagents are less regulated, easier to obtain legally, and maintain the synthesis efficiency needed for effective Fmoc deprotection, thereby resolving the regulatory compliance issue.
Solution Approach 2:
The patent changes the chemical identity of the reagent from piperidine to other amine bases with different regulatory statuses. This parameter change maintains the necessary chemical functionality for efficient synthesis while eliminating the regulatory problems associated with piperidine's use in illegal drug manufacturing.
4Productivity
If traditional Fmoc deprotection reagents are used, then synthesis can be performed, but costs are high and availability is limited
Solution Approach 1:
The patent substitutes expensive and hard-to-obtain piperidine with cheaper, more readily available alternative amine bases such as dibutylamine, dipropylamine, or diethylamine. These reagents are less expensive, more easily obtainable through standard chemical suppliers, and maintain the synthesis capability needed for Fmoc deprotection, thereby improving cost-effectiveness and availability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Dibutylamine or dipropylamine effectively minimizes aspartimide formation, resulting in higher peptide yields and simplified synthesis processes, even at elevated temperatures, thus overcoming the limitations of traditional reagents like piperidine and piperazine.
Implementation Method 1
it acts both as an efficient base to trigger β-elimination of carbamic acid
Implementation Method 2
as nucleophile to quench the reactive dibenzofulvene by-product
Implementation Method 3
allowing for higher reaction temperatures and improved peptide yields
Data Source
AI summary
The invention relates to a method for the preparation of peptides via solid-phase peptide synthesis and particularly to a method of deprotecting of an Fmoc protected amino acid building block linked to a resin R-AA-(AA)n-PF.